| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443599 | European Journal of Cancer | 2014 | 12 Pages |
Abstract
There is an urgent need for the development of biomarkers of treatment response, and for a deeper understanding of tumour heterogeneity and the molecular biology underlying the disease. In this review, we attempt to provide insight into the novel molecular targets showing promise in clinical trials.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
D. Lorente, J.S. De Bono,